Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

[Use of medication in combination with a modern group programme for smoking cessation].

Erfurt L, Kröger CB.

Gesundheitswesen. 2015 Feb;77(2):74-80. doi: 10.1055/s-0034-1367039. Epub 2014 Apr 2. German.

PMID:
24696369
2.

'Real-world' effectiveness of smoking cessation treatments: a population study.

Kotz D, Brown J, West R.

Addiction. 2014 Mar;109(3):491-9. doi: 10.1111/add.12429. Epub 2013 Dec 20.

PMID:
24372901
3.

A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking.

Chan SS, Leung DY, Abdullah AS, Wong VT, Hedley AJ, Lam TH.

Addiction. 2011 Jun;106(6):1155-63. doi: 10.1111/j.1360-0443.2011.03363.x. Epub 2011 Mar 7.

PMID:
21226883
4.

Implementing a hospital-based smoking cessation programme: evidence for a learning effect.

Raupach T, Shahab L, Neubert K, Felten D, Hasenfuss G, Andreas S.

Patient Educ Couns. 2008 Feb;70(2):199-204. Epub 2007 Nov 26.

PMID:
18031972
5.

Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.

Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):111-8. doi: 10.1016/j.drugalcdep.2011.03.005. Epub 2011 Apr 19.

6.

The SCIDOTS Project: evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes.

Awaisu A, Nik Mohamed MH, Mohamad Noordin N, Abd Aziz N, Syed Sulaiman SA, Muttalif AR, Ahmad Mahayiddin A.

Subst Abuse Treat Prev Policy. 2011 Sep 23;6:26. doi: 10.1186/1747-597X-6-26.

7.

Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.

Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009670. doi: 10.1002/14651858.CD009670.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;10:CD009670.

PMID:
23235680
8.

[Evaluation of a none sequential smoking cessation programme in rehabilitation centres].

Birk T, Kröger CB, Piontek D, Nowak D.

Rehabilitation (Stuttg). 2014 Oct;53(5):334-40. doi: 10.1055/s-0034-1384596. Epub 2014 Sep 4. German.

PMID:
25188204
9.

Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.

Bailey SR, Crew EE, Riske EC, Ammerman S, Robinson TN, Killen JD.

Paediatr Drugs. 2012 Apr 1;14(2):91-108. doi: 10.2165/11594370-000000000-00000. Review.

10.

Acceptability and outcome of an Internet-based smoking cessation programme.

Fraser T, McRobbie H, Bullen C, Whittaker R, Barlow D.

Int J Tuberc Lung Dis. 2010 Jan;14(1):113-8.

PMID:
20003704
11.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
12.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
13.

Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation services.

Buller DB, Halperin A, Severson HH, Borland R, Slater MD, Bettinghaus EP, Tinkelman D, Cutter GR, Woodall WG.

J Public Health Manag Pract. 2014 Mar-Apr;20(2):E7-E15. doi: 10.1097/PHH.0b013e3182a0b8c7.

14.

Feasibility of offering nicotine replacement therapy as a relapse prevention treatment in routine smoking cessation services.

Turner J, McNeill A, Coleman T, Bee JL, Agboola S.

BMC Health Serv Res. 2013 Feb 1;13:38. doi: 10.1186/1472-6963-13-38.

15.

An intensive group therapy programme for smoking cessation using nicotine patch and internet mailing supports in a university setting.

Hotta K, Kinumi K, Naito K, Kuroki K, Sakane H, Imai A, Kobayashi M, Ohnishi M, Ogura T, Miura H, Takahashi Y, Tobe K.

Int J Clin Pract. 2007 Dec;61(12):1997-2001.

PMID:
17997805
16.

Predictors of smoking cessation medication use among nonobese and obese smokers.

Yang M, Mehta HB, Bhowmik D, Essien EJ, Abughosh SM.

Subst Use Misuse. 2014 May;49(6):752-61. doi: 10.3109/10826084.2014.880121. Epub 2014 Feb 4.

PMID:
24494623
17.

[Smoking cessation in rehabilitation centres: outcome and predictors of participation].

Wenig JR, Kröger CB, Nowak D.

Rehabilitation (Stuttg). 2014 Aug;53(4):245-50. doi: 10.1055/s-0033-1358735. Epub 2014 Jan 3. German.

PMID:
24390874
18.

Group behaviour therapy programmes for smoking cessation.

Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001007. Review.

PMID:
15846610
19.

Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.

Balmford J, Borland R, Hammond D, Cummings KM.

Nicotine Tob Res. 2011 Feb;13(2):94-102. doi: 10.1093/ntr/ntq215. Epub 2010 Dec 8.

20.

The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.

Walker N, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, Laugesen M, Parag V, Whittaker R.

Addiction. 2012 Oct;107(10):1857-67. doi: 10.1111/j.1360-0443.2012.03906.x. Epub 2012 May 17.

PMID:
22594651
Items per page

Supplemental Content

Write to the Help Desk